Literature DB >> 29731019

Evolving Trends in the Epidemiology, Risk Factors, and Prevention of Type 2 Diabetes: A Review.

Alanna Weisman1, Ghazal S Fazli2, Ashley Johns3, Gillian L Booth4.   

Abstract

Currently, the global prevalence of diabetes is 8.8%. This figure is expected to increase worldwide, with the largest changes projected to occur in low- and middle-income countries. The aging of the world's population and substantial increases in obesity have contributed to the rise in diabetes. Global shifts in lifestyles have led to the adoption of unhealthy behaviours such as physical inactivity and poorer-quality diets. Correspondingly, diabetes is a rapidly-increasing problem in higher- as well as lower-income countries. In Canada, the prevalence of diabetes increased approximately 70% in the past decade. Although diabetes-related mortality rates have decreased in Canada, the number of people affected by diabetes has continued to grow because of a surge in the number of new diabetes cases. Non-European ethnic groups and individuals of lower socioeconomic status have been disproportionately affected by diabetes and its risk factors. Clinical trials have proven efficacy in reducing the onset of diabetes in high-risk populations through diet and physical activity interventions. However, these findings have not been broadly implemented into the Canadian health care context. In this article we review the evolving epidemiology of type 2 diabetes, with regard to trends in occurrence rates and prevalence; the role of risk factors including those related to ethnicity, obesity, diet, physical activity, socioeconomic status, prediabetes, and pregnancy; and the identification of critical windows for lifestyle intervention. Identifying high-risk populations and addressing the upstream determinants and risk factors of diabetes might prove to be effective diabetes prevention strategies to curb the current diabetes epidemic.
Copyright © 2018 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29731019     DOI: 10.1016/j.cjca.2018.03.002

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  19 in total

Review 1.  Posttranslational modifications in diabetes: Mechanisms and functions.

Authors:  Bin Chen; Jianing Zhong; Ang Hu; Haohong Zou
Journal:  Rev Endocr Metab Disord       Date:  2022-06-13       Impact factor: 9.306

2.  Arabic version of the simplified diabetes knowledge scale: psychometric and linguistic validation.

Authors:  Maali Haoues; Chekib Zedini; Molka Chadli-Chaieb
Journal:  Pan Afr Med J       Date:  2022-04-28

3.  Effect of high-fat diet-induced obesity on the small-conductance Ca2+-activated K+ channel function affecting the contractility of rat detrusor smooth muscle.

Authors:  Ning Li; Honglin Ding; Zizheng Li; Yili Liu; Ping Wang
Journal:  Int Urol Nephrol       Date:  2018-10-25       Impact factor: 2.370

4.  Statins exacerbate glucose intolerance and hyperglycemia in a high sucrose fed rodent model.

Authors:  Sriram Seshadri; Naimisha Rapaka; Bhumika Prajapati; Dipeeka Mandaliya; Sweta Patel; Christopher Shamir Muggalla; Bandish Kapadia; Phanithi Prakash Babu; Parimal Misra; Uday Saxena
Journal:  Sci Rep       Date:  2019-06-19       Impact factor: 4.379

5.  Sex-Based Differences in Diabetes Prevalence and Risk Factors: A Population-Based Cross-Sectional Study Among Low-Income Adults in China.

Authors:  Hongyan Zhang; Jingxian Ni; Changshen Yu; Yanan Wu; Jingyan Li; Jie Liu; Jun Tu; Xianjia Ning; Qing He; Jinghua Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2019-09-25       Impact factor: 5.555

6.  Challenges to diabetes self-management for adults with type 2 diabetes in low-resource settings in Mexico City: a qualitative descriptive study.

Authors:  Robin Whittemore; Mireya Vilar-Compte; Selene De La Cerda; Denise Marron; Rosabelle Conover; Roberta Delvy; Annel Lozano-Marrufo; Rafael Pérez-Escamilla
Journal:  Int J Equity Health       Date:  2019-08-23

7.  Rosiglitazone metformin adduct inhibits hepatocellular carcinoma proliferation via activation of AMPK/p21 pathway.

Authors:  Yuyang Liu; Xiangnan Hu; Xuefeng Shan; Ke Chen; Hua Tang
Journal:  Cancer Cell Int       Date:  2019-01-11       Impact factor: 5.722

8.  Acid Hydrolyzed Silk Peptide Consumption Improves Anti-Diabetic Symptoms by Potentiating Insulin Secretion and Preventing Gut Microbiome Dysbiosis in Non-Obese Type 2 Diabetic Animals.

Authors:  Sunmin Park; Ting Zhang; Jing Yi Qiu; Xuangao Wu; Jeong-Yong Lee; Boo-Yong Lee
Journal:  Nutrients       Date:  2020-01-24       Impact factor: 5.717

9.  Impaired glucose regulation, depressive symptoms, and health-related quality of life.

Authors:  Jannica S Selenius; Niko S Wasenius; Hannu Kautiainen; Minna Salonen; Mikaela von Bonsdorff; Johan G Eriksson
Journal:  BMJ Open Diabetes Res Care       Date:  2020-10

10.  Lean body mass and risk of type 2 diabetes - a Danish cohort study.

Authors:  Christine Friis Baker; Kim Overvad; Christina Catherine Dahm
Journal:  J Diabetes Metab Disord       Date:  2019-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.